Fibrosis

Disease State Hub

FDA Alerts

FDA Alert

FDA Approves Injection Therapy for Metabolic-Associated Steatohepatitis in Adults with Moderate to Advanced Fibrosis

08/25/2025

Kate Young

The FDA has announced the approval of the semaglutide injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis following promising interim analysis data. ...

08/25/2025

Research Summaries

FDA Alert

FDA Approves Injection Therapy for Metabolic-Associated Steatohepatitis in Adults with Moderate to Advanced Fibrosis

08/25/2025

Kate Young

08/25/2025

research summary

CVD Risk Is Increased in Patients with HIV and NAFLD, Liver Fibrosis

04/26/2023

Leigh Precopio

To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...

04/26/2023

fibrosis

Prolactin Production in Uterine Fibroids May Contribute to Their Fibrogenicity

11/03/2018

Prolactin may directly contribute to the fibrogenicity of uterine fibroids, according to the results of a new study from the University of Rochester Medical Center in New

11/03/2018

fibrosis

Aging Accelerates Liver Fibrosis Progression Among Women with HIV/HCV

11/01/2017

In a recent study, researchers investigated the impact of reproductive aging on progression among women co-infected with HIV and HCV.

11/01/2017

fibrosis

New Analysis Determines Factors Associated with NASH Disease Progression

04/21/2017

A recent study examined the association between NASH Activity Score and changes in fibrosis to determine better endpoints for assessing disease progression in patients with NASH.

04/21/2017

April 2026

Current Issue

April 2026